Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 57

1.

Soil nematode abundance and functional group composition at a global scale.

van den Hoogen J, Geisen S, Routh D, Ferris H, Traunspurger W, Wardle DA, de Goede RGM, Adams BJ, Ahmad W, Andriuzzi WS, Bardgett RD, Bonkowski M, Campos-Herrera R, Cares JE, Caruso T, de Brito Caixeta L, Chen X, Costa SR, Creamer R, Mauro da Cunha Castro J, Dam M, Djigal D, Escuer M, Griffiths BS, Gutiérrez C, Hohberg K, Kalinkina D, Kardol P, Kergunteuil A, Korthals G, Krashevska V, Kudrin AA, Li Q, Liang W, Magilton M, Marais M, Martín JAR, Matveeva E, Mayad EH, Mulder C, Mullin P, Neilson R, Nguyen TAD, Nielsen UN, Okada H, Rius JEP, Pan K, Peneva V, Pellissier L, Carlos Pereira da Silva J, Pitteloud C, Powers TO, Powers K, Quist CW, Rasmann S, Moreno SS, Scheu S, Setälä H, Sushchuk A, Tiunov AV, Trap J, van der Putten W, Vestergård M, Villenave C, Waeyenberge L, Wall DH, Wilschut R, Wright DG, Yang JI, Crowther TW.

Nature. 2019 Aug;572(7768):194-198. doi: 10.1038/s41586-019-1418-6. Epub 2019 Jul 24.

PMID:
31341281
2.

[A case of spinal and bulbar muscular atrophy with improved walking ability following gait training using the hybrid assistive limb (HAL)].

Mizui D, Nakai Y, Okada H, Kanai M, Yamaguchi K.

Rinsho Shinkeigaku. 2019 Mar 28;59(3):157-159. doi: 10.5692/clinicalneurol.cn-001223. Epub 2019 Feb 28. Japanese.

PMID:
30814446
3.

Transdermal anti-nuclear kappaB siRNA therapy for atopic dermatitis using a combination of two kinds of functional oligopeptide.

Ibaraki H, Kanazawa T, Takashima Y, Okada H, Seta Y.

Int J Pharm. 2018 May 5;542(1-2):213-220. doi: 10.1016/j.ijpharm.2018.03.026. Epub 2018 Mar 15.

PMID:
29551748
4.

Successful combination immunotherapy of anti-gamma aminobutyric acid (GABA)A receptor antibody-positive encephalitis with extensive multifocal brain lesions.

Fukami Y, Okada H, Yoshida M, Yamaguchi K.

Rinsho Shinkeigaku. 2017 Aug 31;57(8):436-440. doi: 10.5692/clinicalneurol.cn-001038. Epub 2017 Jul 22. Japanese.

PMID:
28740064
5.

Development of an Innovative Intradermal siRNA Delivery System Using a Combination of a Functional Stearylated Cytoplasm-Responsive Peptide and a Tight Junction-Opening Peptide.

Ibaraki H, Kanazawa T, Takashima Y, Okada H, Seta Y.

Molecules. 2016 Sep 24;21(10). pii: E1279. doi: 10.3390/molecules21101279.

6.

Inflammatory Pseudotumor of the Brain Parenchyma with IgG4 Hypergammaglobulinemia.

Tanji H, Okada H, Igari R, Yamaguchi Y, Sato H, Takahashi Y, Koyama S, Arawaka S, Wada M, Kawanami T, Wakabayashi K, Kato T.

Intern Med. 2016;55(14):1911-6. doi: 10.2169/internalmedicine.55.5854. Epub 2016 Jul 15.

7.

Topical Anti-Nuclear Factor-Kappa B Small Interfering RNA with Functional Peptides Containing Sericin-Based Hydrogel for Atopic Dermatitis.

Kanazawa T, Shizawa Y, Takeuchi M, Tamano K, Ibaraki H, Seta Y, Takashima Y, Okada H.

Pharmaceutics. 2015 Sep 7;7(3):294-304. doi: 10.3390/pharmaceutics7030294.

8.

Functional peptide nanocarriers for delivery of novel anti-RelA RNA interference agents as a topical treatment of atopic dermatitis.

Kanazawa T, Hamasaki T, Endo T, Tamano K, Sogabe K, Seta Y, Ohgi T, Okada H.

Int J Pharm. 2015 Jul 15;489(1-2):261-7. doi: 10.1016/j.ijpharm.2015.05.003. Epub 2015 May 5.

PMID:
25956048
9.

Versatile nuclear localization signal-based oligopeptide as a gene vector.

Kanazawa T, Yamazaki M, Fukuda T, Takashima Y, Okada H.

Biol Pharm Bull. 2015;38(4):559-65. doi: 10.1248/bpb.b14-00706.

10.

Neuromyelitis optica preceded by hyperCKemia and a possible association with coxsackie virus group A10 infection.

Okada H, Wada M, Sato H, Yamaguchi Y, Tanji H, Kurokawa K, Kawanami T, Takahashi T, Kato T.

Intern Med. 2013;52(23):2665-8.

11.

Cytoplasm-responsive nanocarriers conjugated with a functional cell-penetrating peptide for systemic siRNA delivery.

Tanaka K, Kanazawa T, Horiuchi S, Ando T, Sugawara K, Takashima Y, Seta Y, Okada H.

Int J Pharm. 2013 Oct 15;455(1-2):40-7. doi: 10.1016/j.ijpharm.2013.07.069. Epub 2013 Aug 1.

PMID:
23911914
12.

Needle-free intravaginal DNA vaccination using a stearoyl oligopeptide carrier promotes local gene expression and immune responses.

Kanazawa T, Tamura T, Yamazaki M, Takashima Y, Okada H.

Int J Pharm. 2013 Apr 15;447(1-2):70-4. doi: 10.1016/j.ijpharm.2013.02.018. Epub 2013 Feb 27.

PMID:
23454850
13.

[Non-invasive ophthalmic liposomes for nucleic acid delivery to posterior segment of eye].

Takashima Y, Tsuchiya T, Igarashi Y, Kanazawa T, Okada H, Urtti A.

Yakugaku Zasshi. 2012;132(12):1365-70. Review. Japanese.

14.

Development of a novel and customizable two-solution mixing type spray nozzle for one-step preparation of nanoparticle-containing microparticles.

Ozeki T, Akiyama Y, Takahashi N, Tagami T, Tanaka T, Fujii M, Okada H.

Biol Pharm Bull. 2012;35(11):1926-31.

15.

Improved bioavailability of a water-insoluble drug by inhalation of drug-containing maltosyl-β-cyclodextrin microspheres using a four-fluid nozzle spray drier.

Ozeki T, Kano Y, Takahashi N, Tagami T, Okada H.

AAPS PharmSciTech. 2012 Dec;13(4):1130-7. doi: 10.1208/s12249-012-9826-z. Epub 2012 Sep 1.

16.

Improved intestinal absorption of a poorly water-soluble oral drug using mannitol microparticles containing a nanosolid drug dispersion.

Nishino Y, Kubota A, Kanazawa T, Takashima Y, Ozeki T, Okada H.

J Pharm Sci. 2012 Nov;101(11):4191-200. doi: 10.1002/jps.23278. Epub 2012 Aug 2.

PMID:
22864998
17.

Vaginal DNA vaccination against infectious diseases transmitted through the vagina.

Kanazawa T, Takashima Y, Okada H.

Front Biosci (Elite Ed). 2012 Jun 1;4:2340-53. Review.

PMID:
22652641
18.

Suppression of tumor growth by systemic delivery of anti-VEGF siRNA with cell-penetrating peptide-modified MPEG-PCL nanomicelles.

Kanazawa T, Sugawara K, Tanaka K, Horiuchi S, Takashima Y, Okada H.

Eur J Pharm Biopharm. 2012 Aug;81(3):470-7. doi: 10.1016/j.ejpb.2012.04.021. Epub 2012 May 2.

PMID:
22579732
20.

Improvement of survival in C6 rat glioma model by a sustained drug release from localized PLGA microspheres in a thermoreversible hydrogel.

Ozeki T, Kaneko D, Hashizawa K, Imai Y, Tagami T, Okada H.

Int J Pharm. 2012 May 10;427(2):299-304. doi: 10.1016/j.ijpharm.2012.02.012. Epub 2012 Feb 16. Erratum in: Int J Pharm. 2012 Jul 1;430(1-2):393.

PMID:
22366485

Supplemental Content

Loading ...
Support Center